key: cord-0013982-4coluqp2
authors: Liang, Bo
title: Structures of the Mononegavirales Polymerases
date: 2020-10-27
journal: J Virol
DOI: 10.1128/jvi.00175-20
sha: 591269a2ac16eb1eeeecdb0aa7e66cc277a655f4
doc_id: 13982
cord_uid: 4coluqp2

Mononegavirales, known as nonsegmented negative-sense (NNS) RNA viruses, are a class of pathogenic and sometimes deadly viruses that include rabies virus (RABV), human respiratory syncytial virus (HRSV), and Ebola virus (EBOV). Unfortunately, no effective vaccines and antiviral therapeutics against many Mononegavirales are currently available. Viral polymerases have been attractive and major antiviral therapeutic targets. Therefore, Mononegavirales polymerases have been extensively investigated for their structures and functions. Mononegavirales mimic RNA synthesis of their eukaryotic counterparts by utilizing multifunctional RNA polymerases to replicate entire viral genomes and transcribe viral mRNAs from individual viral genes as well as synthesize 5′ methylated cap and 3′ poly(A) tail of the transcribed viral mRNAs. The catalytic subunit large protein (L) and cofactor phosphoprotein (P) constitute the Mononegavirales polymerases. In this review, we discuss the shared and unique features of RNA synthesis, the monomeric multifunctional enzyme L, and the oligomeric multimodular adapter P of Mononegavirales. We outline the structural analyses of the Mononegavirales polymerases since the first structure of the vesicular stomatitis virus (VSV) L protein determined in 2015 and highlight multiple high-resolution cryo-electron microscopy (cryo-EM) structures of the polymerases of Mononegavirales, namely, VSV, RABV, HRSV, human metapneumovirus (HMPV), and human parainfluenza virus (HPIV), that have been reported in recent months (2019 to 2020). We compare the structures of those polymerases grouped by virus family, illustrate the similarities and differences among those polymerases, and reveal the potential RNA synthesis mechanisms and models of highly conserved Mononegavirales. We conclude by the discussion of remaining questions, evolutionary perspectives, and future directions.

ing Mononegavirales often transmit cross-species and cause severe diseases with high mortality rates, such as NIAID category A priority pathogens Ebola virus (EBOV) and Marburg virus (MRAV) from Filoviridae and NIAID category C priority pathogens rabies virus (RABV) from Rhabdoviridae and Nipah virus (NiV) and Hendra virus (HeV) from Paramyxoviridae (1, (12) (13) (14) (15) (16) (17) . The representative viruses of Mononegavirales are listed in Table 1 . Currently, no effective vaccine or antiviral therapy is available to prevent or treat many of those NNS RNA viral pathogens (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) .

Mononegavirales are enveloped viruses with various morphologies for different families; for example, Rhabdoviridae are bullet-shaped, Paramyxoviridae are pleomorphic or spherical, and Filoviridae are filamentous (30) (31) (32) . The genome organization and replication of Mononegavirales have been extensively studied for decades (1) (2) (3) . The NNS RNA viral genomes are linear and single-stranded, and their lengths range from 8.9 to 19.0 kilobases (1) (2) (3) . Mononegavirales encode 5 to 10 genes, with 4 core genes shared by all members. Those core genes (Fig. 1 , blue boxes) encode four shared proteins, nucleoprotein (N or NP), phosphoprotein (P or VP35), matrix protein (M), and large protein (L). Three out of four shared proteins, namely, N, P, and L, constitute the RNA synthesis machine, suggesting the central role of RNA synthesis in the Mononegavirales life cycle (33) (Fig. 1) .

Mononegavirales initiate viral infection by delivering into the host cell a virus-specific RNA synthesis machine (33) (34) (35) . The template for RNA synthesis is not RNA alone but rather a complex of the viral genomic RNA completely encapsidated by the N or NP, called nucleocapsid (NC) (36) . This NC template is copied by the viral RNA-dependent RNA polymerase (RdRP), which comprises L and cofactor P or VP35 (37) (38) (39) (40) (41) (42) (43) . Additional viral proteins M2-1 in Pneumoviridae and VP30 and VP24 in Filoviridae are essential for full processivity (44) (45) (46) (47) (48) . The L protein has all the enzymatic activities necessary for the transcription of the viral mRNAs, including RNA polymerization, 5= cap addition, cap methylation, and 3= polyadenylation, as well as the replication of the viral genome (38, (49) (50) (51) (52) (53) (54) (55) (56) (57) . Thus, L is the catalytic core of a multicomponent and multifunctional RNA synthesis machine.

The RNA polymerase is the sole enzyme of Mononegavirales, and there is a critical need to delineate the molecular and structural basis of the RNA polymerase of Mononegavirales (58) . Since the first structure of the L protein alone of vesicular stomatitis virus (VSV) was determined in 2015 (59) , multiple structures of RNA polymerases of Mononegavirales, including HRSV, HMPV, RABV, HPIV, and VSV, have been reported in recent months, revealing the architectures of L:P complexes and interactions between L and P (59) (60) (61) (62) (63) (64) . This review illustrates similarities and differences among the polymerases by comparing the structures of those polymerases and revealing the potential RNA synthesis mechanisms of the highly conserved Mononegavirales polymerases. 

The multimodular adapter P protein of Mononegavirales is an oligomeric and nonglobular molecule in solution (83) . Although L contains all catalytic functions, P is the essential cofactor required for L to synthesize RNA effectively (38) . P not only is the cofactor of L but also acts as an adapter to coordinate and modulate multiple proteins, including RNA-free N protein, NC complex, and additional regulatory proteins (84, 85) . Notably, P forms dimers in Rhabdoviridae (83, 86, 87) , trimers or tetramers in Filoviridae (88, 89) , and tetramers in Paramyxoviridae and Pneumoviridae (90) (91) (92) (93) (94) . Each P protomer consists of an intrinsically disordered N-terminal domain (P NTD ), an oligomerization domain (P OD ), and a C-terminal domain (P CTD ), connecting with a flexible linker (83) . Despite a high diversity in length, sequence, and even in the structural folds of individual domains, this modular architecture is conserved among different Mononegavirales (Fig. 2B ). The intrinsically disordered P NTD exhibits a substantial conformational heterogeneity and is essential for its dynamic coordination functions. The key features of P can be revealed as the modular architecture with intrinsically disordered domains and structural domains that interact with different proteins that constitute the RNA synthesis machine (95) (96) (97) (98) (99) . Interestingly, the length difference seems to correlate with additional functions of the adapter P protein. For example, the linker between P OD and P CTD of RABV is longer than that of VSV and contains a dynein light chain 8 (LC8) binding site (100); P CTD of EBOV contains an additional region for RNA binding and innate immune escape (101) . Furthermore, P is often phosphorylated by the host kinases, and phosphorylation is essential for its regulation of RNA synthesis (102) (103) (104) (105) (106) (107) .

Together, this information suggests that P plays the following critical roles within the RNA synthesis machine: (i) P is an essential cofactor to regulate the processivity of L. As an adapter, P interacts with NC and bridge in the RNA to thread into the L active sites during transcription and replication (108) (109) (110) (111) (112) (113) . (ii) P acts as a chaperone to maintain a supply of RNA-free N (N 0 ) and delivers to N 0 nascent RNA genome or antigenome during replication (98, 99, (114) (115) (116) (117) (118) . (iii) P interacts with other essential cofactors, such as M2-1 in Pneumoviridae and VP30 in Filoviridae, to coordinate the RNA synthesis activities of the RdRP (48, (119) (120) (121) (122) .

The monomeric L and oligomeric P together constitute the RdRP in Mononegavirales. Due to the large size of L and the oligomeric states of P with intrinsically flexible domains, it is challenging to obtain the crystals of the Mononegavirales RdRPs (123) . The recent advance of cryo-electron microscopy (cryo-EM) offers an alternative way for a high-resolution structural characterization of such macromolecular complexes (124) .

In 2015, the cryo-EM structure of the VSV L was determined at 3.8-Å resolution (PDB: 5A22) (125) , and it was the first structure of the Mononegavirales polymerases. Although the VSV L was prepared in the complex of the VSV P NTD , the structure allowed only the de novo model building of the entire L protein but not the model assignment of P NTD , despite extra electron density observed (125) . Since 2015, there have been many attempts for the structural characterizations of the Mononegavirales polymerases. For example, crystal structures of NTD and CTD fragments of L have also been reported (126, 127) . In recent months, there were multiple successful cases of the structural characterization of the Rhabdoviridae and Pneumoviridae polymerases by cryo-EM, one for RABV (PDB: 6UEB), one for VSV (P NTD visible; PDB: 6U1X), two for HRSV (PDBs: 6PZK and 6UEN), one for HMPV (PDB: 6U5O), and one for HPIV (PDB: 6V85) (59) (60) (61) (62) (63) . For consistency, the domain organizations and cartoon representations of the individual structures are colored as follows: RdRp (blue), Cap (green), CD (yellow), MT (pink), and CTD (cyan) for L; and P NTD (magenta), P OD (red), and P CTD (orange) for P (the same as Fig. 2 ).

A higher 3.0-Å resolution cryo-EM structure of the VSV polymerase (PDB: 6U1X) was reported that enables the visualization of not only the 2,109-residue VSV L but also the bound P NTD of the 265-residue VSV P (59, 125) (Fig. 3A) . The root mean square deviation (RMSD) between 3.8-Å and 3.0-Å structures of VSV L is 1.33 Å (59, 125) . All five domains of the VSV L except a few flexible linkers are visible in the structure, including three functional domains, namely, RdRp (35 to 865), Cap (866 to 1334), and MT (1598 to 1892), and two structural domains, namely, the connector domain (CD; 1335 to 1597) and the C-terminal domain (CTD; 1893 to 2109) (59) (Fig. 3A) . The RdRp domain resembles the classical RNA polymerase fold. The Cap domain folds next to the RdRp domain, and there was no homology for the Cap domain outside the order of Mononegavirales due to the unique capping mechanism. The CD domain connects the Cap and MT domains, and the CTD domain folds back to be close to the RdRp domain. The three ordered segments 49 to 56, 82 to 89, and 94 to 105 of P NTD (1 to 106) are shown to interact with CTD, RdRp, and CD domains of L, respectively (59, 125) (Fig. 3A) . There are 35.05% and 19.22% amino acid identities between VSV and RABV L and P protein, respectively. As expected, VSV and RABV L share high similarity, with a nearly complete conservation of secondary structure elements throughout the protein. Despite having a greater sequence difference, VSV P and RABV P are also structurally similar to each other. Interestingly, there is a flexible loop (1158 to 1172 in VSV and 1171 to 1186 in RABV) in the Cap domain of Rhabdoviridae L that is against the active site of the RdRp domain. This loop is identified as the priming loop responsible for the de novo initiation of RNA synthesis (59, 60, 125) . Due to the compact packing of the RdRp and Cap domains, the position of the priming loop appears to block the putative RNA product exit channel. Therefore, it is believed that Rhabdoviridae L adopts an initiation state in the structures, and significant rearrangements of those domains are likely to occur during elongation and other states of RNA synthesis.

Multiple cryo-EM structures of the Pneumoviridae polymerases have also been reported in recent months, including a 3.2-Å (PDB: 6PZK) and a 3.67-Å (PDB: 6UEN) resolution structures of the HRSV polymerase and a 3.7-Å resolution structure of the HMPV polymerase (PDB: 6U5O) (61) (62) (63) . Two structures of the HRSV polymerase are nearly identical, with an RMSD of 1.48 Å (61, 63) (Fig. 4A) . The structures reveal that the RdRp (10 to 945) and Cap (946 to 1461) domains of the 2,165-residue L interact with the P OD (128 to 157) and P CTD (158 to 241) of a tetramer of the 241-residue P. Interestingly, although full-length L and P were used to reconstitute the HRSV polymerases, the EM densities of MT domain and structural CD and CTD domains of the L and the P NTD are missing in 3-dimensional (3D) reconstructions (61, 63) (Fig. 4A , missing domains are shown in gray). The integrity of proteins was confirmed by mass spectrometry. The missing EM densities suggest that the intrinsic flexibility of those domains (61) and P OD and P CTD are not sufficient to lock those domains of L into a homogenous conformation. Interestingly, four protomers of the tetrameric HRSV P OD and P CTD adopt distinct conformation, and each of the promoters uses different ranges of residues, namely, 128 to 182, 128 to 187, 128 to 202, and 128 to 241, to interact with distinct regions of HRSV L (Fig. 4A) . A further comparison of structures reveals slightly different intermolecular arrangements among L and tetrameric P, suggesting the plasticity of the L:P interface for structural rearrangements during RNA synthesis (61) .

The structure of the HMPV polymerase (PDB: 6U5O) shares a highly similar architecture to that of the HRSV polymerase, which contains the RdRp (8 to 902) and Cap (903 to 1380) domains of the 2,005-residue HMPV L and P OD (168 to 193) and P CTD (194 to 266) of a tetramer of the 294-residue HMPV P (62) . The RMSD between the HRSV and HMPV L is 1.49 Å. The HMPV polymerase also lacks the MT and other structural domains (CD and CTD) of L and P NTD in the 3D reconstructions (62) (Fig. 4B) . Similarly, each of the four protomers of the tetrameric HMPV P OD and P CTD adopts a distinct conformation and uses different ranges of residues, namely, 168 to 219, 168 to 231, 168 to 236, and 168 to 266, to interact with HMPV L (Fig. 4B ).

There are high sequence identities between the HRSV and HMPV L and P, namely, 49.12%, and 37.18%, respectively. As expected, HRSV and HMPV polymerases share highly similar architectures between them, including the priming loop. Surprisingly, the priming loop in the Cap domain of the Pneumoviridae L shows a substantial shift and ϳ37 Å away from the active sites of the RdRp domain, suggesting that L adopts an elongation state in the structures (61) (62) (63) . Despite the similarities, there are several noticeable differences between the structures of HRSV and HMPV polymerases, as follows: (i) HRSV L contains an insertion (134 to 176) compared with that of HMPV L; (ii) HRSV L has a missing connecting helix (660 to 691), but the equivalent connecting helix of HMPV L can be partially modeled; (iii) one protomer of the HRSV P tetramers shows a different arrangement compared with its counterpart protomer of the HMPV P. Those slight differences between the two genera Metapneumovirus and Orthopneumovirus are likely due to genus-specific features of the RNA synthesis machine, and more detailed comparisons can be found in reference 128.

Cryo-EM structures of the Paramyxoviridae polymerases have also been reported, (Fig. 5A) . Interestingly, although all five domains of HPIV L are presented, the CTD adopts a significant domain switch compared with that of the Rhabdoviridae L (Fig. 5B) . The two conformations of the HPIV polymerase (L:P) are highly similar, with slightly different orientations of the CD-MT-CTD module with respect to RdRp and Cap (Fig. 5B, right panel) . Furthermore, in contrast to Pneumoviridae P, only one protomer of P CTD EM-density is visible in Paramyxoviridae P, suggesting the versatile roles of P in RNA synthesis. It is noticeable that the tetrameric Paramyxoviridae P OD is much longer than that of Rhabdoviridae and Pneumoviridae P OD , highlighting the potential mechanistic differences among those families.

The L proteins of Rhabdoviridae, Pneumoviridae, and Paramyxoviridae have similar lengths (2,000 to 2,300 residues) and share a similar architecture. Indeed, the RdRp domains of Mononegavirales L share a standard right-hand thumb-palm-finger ring-like configuration of RNA and DNA polymerases. Comprehensive comparisons of the RNA/ DNA polymerases and viral polymerases have been extensively reviewed elsewhere (129) (130) (131) (132) (133) (134) (135) (136) . The structural superimpositions of the motifs, namely, fingers, palm, thumb, and structural support, of the RdRp domains of the Mononegavirales L, are shown in blue, red, green, and gray, respectively. The active sites (GDN) of the RdRp domains are shown as magenta spheres (Fig. 6A to E) . For comparison, we also showed the The previous studies highlighted the conserved structural motifs A to E of the Cap domain of L (33, 56, 137) . Unlike the capping in the host cells, the capping reaction of the Mononegavirales L forms a covalent protein:RNA intermediate linkage between the 5= of the RNA transcript and the active site H residue (motif D), followed by the attack by a guanosine nucleotide. The motifs A to E of the Cap domain of the Mononegavirales L are shown as a ribbon diagram in blue, yellow, red, magenta, and green, respectively. Those motifs are centered around the motif D (HR) active site. The proposed priming loops (orange) are next to the motif B (yellow) but exhibit a dramatic conformational rearrangement (Fig. 7) .

Despite the high similarities, there are several significant differences between the known structures of Mononegavirales polymerases. (i) All five domains (RdRp, Cap, CD, MT, and CTD) of the Rhabdoviridae and Paramyxoviridae L compared with only two domains (RdRp and Cap) of the Pneumoviridae L are visible in the cryo-EM structures. (ii) P forms dimers in Rhabdoviridae but tetramers in Pneumoviridae and Paramyxoviridae. It is thought that P displays distinct structural features due to low sequence identity and different oligomerization states. Interestingly, different domains of P interact with L in the reported structures. In Rhabdoviridae, only the P NTD interacts with mostly CD and CTD and part of RdRp of L (Fig. 8B) . However, in Pneumoviridae and Paramyxoviridae, the P OD and P CTD interact with the RdRp domain of L (59-63) (Fig. 8D  and 8F ). Compared with the oligomeric P shown in Pneumoviridae and Paramyxoviridae, the lack of the P OD in Rhabdoviridae resulted in a monomeric P binding to L. (iii) The priming loop and the supporting helix of L (Fig. 8 , colored in orange) adopt three different conformations, as follows: in Rhabdoviridae (VSV and RABV), the priming loop together with a supporting helix in the RdRp domain project into the GDN active sites (Fig. 8A ) of the RdRp domain and close off a channel toward the Cap domain; in Pneumoviridae (HRSV and HMPV), the supporting helix is (partially) disordered, and the priming loop retracts from the RdRp active sites (Fig. 8C) and opens the channel connecting to the Cap domain; and in Paramyxoviridae (HPIV), the supporting helix is visible (similar as Rhabdoviridae), but the priming loop with a disordered tip is projected away from the RdRp active sites (similar as Pneumoviridae) (Fig. 8E) . 

Collectively, the structures of the Mononegavirales polymerases discussed here reveal multiple distinct conformational arrangements of the L and P proteins, as shown in the cartoon diagrams (Fig. 9A) . The comparison analyses suggest potential RNA synthesis mechanisms of Mononegavirales, switching of initiation, and elongation associated with priming loop and supporting helix rearrangements (59) (60) (61) (62) (63) . Based on the structural similarities and differences among the Mononegavirales polymerases, we hypothesize that (i) the polymerases of the Rhabdoviridae (VSV and RABV) are likely at the initiation stage of genome replication, and (ii) the polymerases of Pneumoviridae (HRSV and HMPV) and Paramyxoviridae (HPIV) are at different phases, possibly late phase and early phase, of the elongation stages of transcription, respectively.

To better understand the RNA synthesis mechanism by the Mononegavirales polymerases, we superimposed other viral polymerase complexes in the initiation and elongation stages. For the initiation, the superimposition of the reovirus (ReoV) 3 initiation complex reveals in the presence of the RNA template (yellow), the initiating nucleotide stacks with a Trp (W1167 in VSV L and W1180 in RABV L) residue of the priming loop, which is also similar to the Y630 in hepatitis C virus (NS5B) (59, 60, 138, 139) (Fig. 9B, left panel) . The mutation of this Trp residue severely affects the genome or antigenome end initiation but not internal initiation or capping (140) . For the elongation, the polymerases require the retraction of the priming loop and possibly the support helix to pave the way to accommodate the product. Indeed, the fully retracted priming loop configurations are observed in both Pneumoviridae (HRSV and HMPV) and Paramyxoviridae (HPIV). The superimpositions of the influenza B (FluB) elongation complexes at early and later stages reveal that the RNA transcripts (pink) have sufficient space to extend and pass through a continuous tunnel when the priming loop is entirely retracted (141) (Fig. 9B, middle and right panels) . The remaining support helix in Paramyxoviridae (HPIV) results in a partially extruded tunnel, where the missing support helix in Pneumoviridae (HRSV and HMPV) leads to a fully open tunnel, which is ideal for highly processive transcription.

As highlighted above, the NC is the cognate RNA template for Mononegavirales RNA synthesis. Based on the structures of Mononegavirales RNA polymerases, we propose the models of the initiation and early and late stage elongation of RNA synthesis, as (Fig. 9C, right panel) . 

Many Mononegavirales are significant human pathogens, imposing a tremendous public threat and health care burden. However, no effective vaccines and antiviral therapeutics against many Mononegavirales are currently available (18-21, 23, 29, 142-148) . Viral polymerases have been attractive and major antiviral therapeutic targets, as seen in multiple drug discovery successes in various viral pathogens, including HIV-1, hepatitis C virus (HCV), and hepatitis B virus (HBV) (149) (150) (151) (152) (153) (154) (155) (156) (157) . Drug design and target search heavily rely on an accurate understanding of the structure and functions of the target molecules. Therefore, various viral polymerases have been extensively investigated for their structures and functions (129, 130) . To understand the mechanistic insights of Mononegavirales RNA synthesis, the precise composition and structure of the Mononegavirales polymerases, how the different activities of the L protein influence one another, and how the cofactor regulates RNA synthesis need to be elucidated.

The structures of the Mononegavirales polymerases discussed here, including the L protein in complex with its cofactor P protein of VSV, RABV, HRSV, HMPV, and HPIV, reveal three conformations poised for initiation and elongation of RNA synthesis (59) (60) (61) (62) (63) . The potential channels and the relative locations of multiple catalytic sites of L suggest that L coordinates a distinct capping and methyltransferase reaction with priming for de novo initiation of transcription. Transcription and replication might have different priming configurations and potential different product exit sites. The high similarity between L and P of the Mononegavirales polymerases provides a structural basis for the development of antiviral drugs that inhibit the RNA synthesis in transcription or replication.

This difference might also explain why L shows different architecture in three different families. P NTD is speculated to lock the CD, MT, and CTD domains into a closed conformation, which represents that L is poised for initiation at the 3= end of the genome or antigenome and ready for RNA synthesis. The interactions between multiple domains of L and the P NTD reveal how P induces a compact, closed, and initiationcompatible state of L and how P positions the RNA template and the putative RNA product exit channel.

Several interesting questions arise by comparing and analyzing the known structures of the Mononegavirales polymerases. First, although the mass spectrometry data indicated that the Pneumoviridae L proteins used in structural studies are intact, the mystery of the missing MT domain and structural domains of L remains. Where do the MT and structural domains (CD and CTD) go? How do we capture the snapshots of their intermediates? Second, the known structures of the Mononegavirales polymerases are protein only without RNA present in the complex. However, those polymerases are in different initiation and elongation-compatible stages. Why do the priming loop and the supporting helix of L adopt different conformations in the protein-only complex? Third, the tetrameric P has a large interaction surface between P OD and L in Pneumoviridae and Paramyxoviridae. Given that P is a dimer in Rhabdoviridae but a tetramer in Pneumoviridae and Paramyxoviridae, is it possible that the dimeric P in Rhabdoviridae may not form a tight complex with L with large interfaces? This may explain why the HRSV, HMPV, and HPIV L need to be coexpressed in the presence of P, but not VSV L, which can be expressed and purified alone.

From an evolutionary perspective, Mononegavirales have evolved to utilize a single multifunctional enzyme to transcribe individual genes (make, cap, and methylate the mRNAs) and replicate the entire genome without capping and methylation. This may be due to reduced evolutionary pressure; typically, this multifaceted process is sensitive to cell state and signaling inputs. These viruses have evolved to drive this process efficiently forward using minimal components. In eukaryotes, RNA transcription (copying the genetic information) is a delicate and complicated process involving many molecular machines, such as DNA-dependent RNA polymerases, capping enzymes, and methyltransferases. For example, the eukaryotic counterparts of the RdRp, Cap, and MT domains of the multifunctional enzyme L are (i) RNA polymerase II and polyadenylate polymerase, (ii) RNA triphosphatase and guanylyltransferase, and (iii) RNA methyltransferase, respectively (158) (159) (160) (161) (162) (163) (164) (165) (166) (167) . Additionally, Mononegavirales L also mimics the replication of the entire genome by accessing the N protein-coated RNA genome, similar to eukaryotic counterparts of DNA polymerases on the histone-assembled DNA genome (168) (169) (170) .

The structural similarity of the Mononegavirales polymerases agrees with the relatively high sequence conservation. Nonetheless, the structural differences also highlight the virus-or genus-specific features. Collectively, the structures of the Mononegavirales polymerases provide significant advances into understanding the molecular architectures, interrelationship, the inhibitors, and the evolutionary implications of the Mononegavirales polymerases. Other polymerases from measles, mumps, Nipah virus, and Hendra virus in Paramyxoviridae and Ebola virus and Marburg virus in Filoviridae need to be determined for us to fully understand the similarities and differences of the polymerases in Mononegavirales. Furthermore, structures of Mononegavirales polymerases in complex with RNA templates, RNA products, or inhibitors are desired to appreciate the specific protein:RNA interactions and druggable sites.

All the figures presenting the structural models were generated using PyMOL (171) .

Mononegavirales

Transcription and replication of nonsegmented negative-strand RNA viruses

Nonsegmented negative-strand RNA viruses: genetics and manipulation of viral genomes

Taxonomy of the order Mononegavirales: update 2019

Taxonomy of the order Mononegavirales: update 2016

Distinct genome replication and transcription strategies within the growing filovirus family

Vaccines for the paramyxoviruses and pneumoviruses: successes, candidates, and hurdles

Respiratory syncytial virus: infection, detection, and new options for prevention and treatment

Measles virus host invasion and pathogenesis

Molecular biology, pathogenesis and pathology of mumps virus

NIAID Emerging infectious diseases/pathogens. www.niaid .nih.gov/research/emerging-infectious-diseases-pathogens

Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies-a comprehensive review

Marburg virus pathogenesis-differences and similarities in humans and animal models

The pathogenesis of Ebola virus disease

Everything you always wanted to know about rabies virus (but were afraid to ask)

Hendra virus

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates

An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route

Ebola and Marburg virus vaccines

Status of vaccine research and development of vaccines for Nipah virus

Progress toward a respiratory syncytial virus vaccine

A treatment for and vaccine against the deadly Hendra and Nipah viruses

Novel therapies and vaccines against the human respiratory syncytial virus

Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism

New antiviral approaches for respiratory syncytial virus and other mononegaviruses: inhibiting the RNA polymerase

Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus

The RNA-dependent-RNA polymerase, an emerging antiviral drug target for the Hendra virus

Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay

Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography

Electron cryotomography of measles virus reveals how matrix protein coats the ribonucleocapsid within intact virions

Cryo-EM model of the bullet-shaped vesicular stomatitis virus

RNA synthesis and capping by non-segmented negative strand RNA viral polymerases: lessons from a prototypic virus

Polymerases of paramyxoviruses and pneumoviruses

Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease

Role of the nucleocapsid protein in regulating vesicular stomatitis virus RNA synthesis

Requirement of casein kinase II-mediated phosphorylation for the transcriptional activity of human respiratory syncytial viral phosphoprotein P: transdominant negative phenotype of phosphorylation-defective P mutants

RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA

A single amino acid substitution in the phosphoprotein of respiratory syncytial virus confers thermosensitivity in a reconstituted RNA polymerase system

Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro

Unravelling the complexities of respiratory syncytial virus RNA synthesis

Two RNA polymerase complexes from vesicular stomatitis virus-infected cells that carry out transcription and replication of genome RNA

Interactome analysis of the human respiratory syncytial virus RNA polymerase complex identifies protein chaperones as important cofactors that promote L-protein stability and RNA synthesis

Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription

Synergistic effects of gene-end signal mutations and the M2-1 protein on transcription termination by respiratory syncytial virus

Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity

Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription

The Ebola virus VP30-NP interaction is a regulator of viral RNA synthesis

Viral RNApolymerases-a predicted 2=-O-ribose methyltransferase domain shared by all Mononegavirales

Transcriptional activity and mutational analysis of recombinant vesicular stomatitis virus RNA polymerase

A single amino acid change in the L-polymerase protein of vesicular stomatitis virus completely abolishes viral mRNA cap methylation

The vesicular stomatitis virus L protein possesses the mRNA methyltransferase activities

Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus

Amino acid residues within conserved domain VI of the vesicular stomatitis virus large polymerase protein essential for mRNA cap methyltransferase activity

A unique strategy for mRNA cap methylation used by vesicular stomatitis virus

A conserved motif in region v of the large polymerase proteins of nonsegmented negative-sense RNA viruses that is essential for mRNA capping

The L protein of vesicular stomatitis virus modulates the response of the polyadenylic acid polymerase to S-adenosylhomocysteine

The polymerase of negative-stranded RNA viruses

Structure of the vesicular stomatitis virus L protein in complex with its phosphoprotein cofactor

Structure of a rabies virus polymerase complex from electron cryo-microscopy

Cryo-EM structure of the respiratory syncytial virus RNA polymerase

Structure of the human metapneumovirus polymerase phosphoprotein complex

Structure of the respiratory syncytial virus polymerase complex

Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation

De novo initiation of viral RNAdependent RNA synthesis

The flavivirus polymerase as a target for drug discovery

Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA

Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus

Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase

Nucleotide sequences of the 3' leader and 5' trailer regions of human respiratory syncytial virus genomic RNA

Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription

Non-gradient and genotype-dependent patterns of RSV gene expression

Level of gene expression is a major determinant of protein evolution in the viral order Mononegavirales

Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus

Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome

Killing two birds with one stone: how the respiratory syncytial virus polymerase initiates transcription and replication

Sequence comparison of five polymerases (L proteins) of unsegmented negativestrand RNA viruses: theoretical assignment of functional domains

Ribose 2=-O methylation of the vesicular stomatitis virus mRNA cap precedes and facilitates subsequent guanine-N-7 methylation by the large polymerase protein

A freeze frame view of vesicular stomatitis virus transcription defines a minimal length of RNA for 5= processing

Vesicular stomatitis virus mRNA capping machinery requires specific cis-acting signals in the RNA

Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation

Opposing effects of inhibiting cap addition and cap methylation on polyadenylation during vesicular stomatitis virus mRNA synthesis

Unphosphorylated rhabdoviridae phosphoproteins form elongated dimers in solution

Role of the hypervariable hinge region of phosphoprotein P of vesicular stomatitis virus in viral RNA synthesis and assembly of infectious virus particles

Phosphorylation of specific serine residues within the acidic domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro

Structure of the dimerization domain of the rabies virus phosphoprotein

Crystal structure of the oligomerization domain of the phosphoprotein of vesicular stomatitis virus

Crystal structure of the Marburg virus VP35 oligomerization domain

Structures of Ebola and Reston virus VP35 oligomerization domains and comparative biophysical characterization in all Ebolavirus species

Crystal structure of the nipah virus phosphoprotein tetramerization domain

Structure of the tetramerization domain of measles virus phosphoprotein

Structural and functional characterization of the mumps virus phosphoprotein

Tetrameric coiled coil domain of Sendai virus phosphoprotein

Solution and crystallographic structures of the central region of the phosphoprotein from human metapneumovirus

Modular organization of rabies virus phosphoprotein

Structural disorder within Henipavirus nucleoprotein and phosphoprotein: from predictions to experimental assessment

Detecting remote sequence homology in disordered proteins: discovery of conserved motifs in the N-termini of Mononegavirales phosphoproteins

Assembly of the Ebola virus nucleoprotein from a chaperoned VP35 complex

An intrinsically disordered peptide from Ebola virus VP35 controls viral RNA synthesis by modulating nucleoprotein-RNA interactions

Interaction of the rabies virus P protein with the LC8 dynein light chain

Structure of the Ebola VP35 interferon inhibitory domain

Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P

Regulation of mumps virus replication and transcription by kinase RPS6KB1

Phosphorylation of Sendai virus phosphoprotein by cellular protein kinase C zeta

Host cell protein kinases in nonsegmented negativestrand virus (mononegavirales) infection

Borna disease virus P-protein is phosphorylated by protein kinase Cepsilon and casein kinase II

Akt plays a critical role in replication of nonsegmented negative-stranded RNA viruses

Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus

Critical phosphoprotein elements that regulate polymerase architecture and function in vesicular stomatitis virus

Fine mapping and characterization of the L-polymerasebinding domain of the respiratory syncytial virus phosphoprotein

Binding of rabies virus polymerase cofactor to recombinant circular nucleoprotein-RNA complexes

Structure of the vesicular stomatitis virus nucleocapsid in complex with the nucleocapsid-binding domain of the small polymerase cofactor

Characterization of a viral phosphoprotein binding site on the surface of the respiratory syncytial nucleoprotein

Identification and characterization of the binding site of the respiratory syncytial virus phosphoprotein to RNA-free nucleoprotein

Ensemble structure of the highly flexible complex formed between vesicular stomatitis virus unassembled nucleoprotein and its phosphoprotein chaperone

Nucleocapsid assembly in pneumoviruses is regulated by conformational switching of the N protein

Crystal structure of the measles virus nucleoprotein core in complex with an N-terminal region of phosphoprotein

Structure of the vesicular stomatitis virus N(0) P complex

The structure of the human respiratory syncytial virus M2-1 protein bound to the interaction domain of the phosphoprotein p defines the orientation of the complex

Crystal structure of the essential transcription antiterminator M2-1 protein of human respiratory syncytial virus and implications of its phosphorylation

Drastic changes in conformational dynamics of the antiterminator M2-1 regulate transcription efficiency in Pneumovirinae

Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome

Where is crystallography going?

Single-particle cryo-EM-how did it get here and where will it go

Structure of the L protein of vesicular stomatitis virus from electron cryomicroscopy

Structure and function of the N-terminal domain of the vesicular stomatitis virus RNA polymerase

X-ray structure and activities of an essential Mononegavirales L-protein domain

Cryo-electron microscopy structures of the Pneumoviridae polymerases

A comprehensive superposition of viral polymerase structures

The extended "two-barrel" polymerases superfamily: structure, function and evolution

Viral RNA-dependent RNA polymerases: a structural overview

A comparison of viral RNA-dependent RNA polymerases

RNA dependent RNA polymerases: insights from structure, function and evolution

A structural overview of RNA-dependent RNA polymerases from the Flaviviridae family

Common and unique features of viral RNAdependent polymerases

RNA-dependent RNA polymerases from Flaviviridae

Signature motifs of GDP polyribonucleotidyltransferase, a non-segmented negative strand RNA viral mRNA capping enzyme, domain in the L protein are required for covalent enzyme-pRNA intermediate formation

RNA synthesis in a cage-structural studies of reovirus polymerase lambda3

Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase

A dual-functional primingcapping loop of rhabdoviral RNA polymerases directs terminal de novo initiation and capping intermediate formation

Structural snapshots of actively transcribing influenza polymerase

Advances in designing and developing vaccines, drugs, and therapies to counter Ebola virus

Chaperoning the Mononegavirales: current knowledge and future directions

Ebola therapeutic study and future directions

Reverse genetics of Mononegavirales: how they work, new vaccines, and new cancer therapeutics. Virology

Vaccines against Ebola virus

Rabies vaccines: WHO position paper

Ebolavirus vaccines: progress in the fight against ebola virus disease

Hepatitis B: current status of therapy and future therapies

Pharmaceutical approaches for treatment of hepatitis C virus

Progress toward hepatitis C virus elimination: therapy and implementation

Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond

Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: a systematic review

Approved antiviral drugs over the past 50 years

Treatment of hepatitis C: a systematic review

HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med 2:a007161

Another ten stories in antiviral drug discovery (part C): "old" and "new" antivirals, strategies, and perspectives

Structural basis of transcription: an RNA polymerase II elongation complex at 3.3 A resolution

Structural basis of transcription: RNA polymerase II at 2.8 angstrom resolution

Mechanism of poly(A) polymerase: structure of the enzyme-MgATP-RNA ternary complex and kinetic analysis

Assembly of a processive messenger RNA polyadenylation complex

Regulation of mRNA cap methylation

Functional interactions of RNA-capping enzyme with factors that positively and negatively regulate promoter escape by RNA polymerase II

mRNA capping enzyme activity is coupled to an early transcription elongation

Structure and mechanism of mRNA cap (guanine-N7) methyltransferase

Integrating mRNA processing with transcription

The guanylyltransferase domain of mammalian mRNA capping enzyme binds to the phosphorylated carboxyl-terminal domain of RNA polymerase II

Eukaryotic DNA replication: orchestrated action of multi-subunit protein complexes

Mechanisms and regulation of DNA replication initiation in eukaryotes

Chromatin replication and histone dynamics

Using the PyMOL application to reinforce visual understanding of protein structure

The research programs in the Liang laboratory at Emory are supported by the U.S. National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH), under award number R01GM130950 and by the Research Start-Up Fund at Emory University School of Medicine.I acknowledge the members of the Liang laboratory for helpful support and critical discussion.I declare that I have no competing interests.